title: Venlafaxine-induced intraocular pressure rise in a patient with open angle glaucoma.
authors.affiliation: Department of Ophthalmology, Waikato District Health Board, Hamilton, New Zealand.
authors.forename: Verona E
authors.initials: VE
authors.lastname: Botha
authors.affiliation: Department of Ophthalmology, Waikato District Health Board, Hamilton, New Zealand.
authors.forename: Riyaz
authors.initials: R
authors.lastname: Bhikoo
authors.affiliation: Department of Ophthalmology, Waikato District Health Board, Hamilton, New Zealand.
authors.forename: Michael
authors.initials: M
authors.lastname: Merriman
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068438:Brimonidine Tartrate / Q000627:therapeutic use; D002908:Chronic Disease; D003866:Depressive Disorder / Q000188:drug therapy; D005902:Glaucoma, Open-Angle / Q000150:complications*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D000077338:Latanoprost; D008297:Male; D008875:Middle Aged; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use; D014065:Tonometry, Ocular; D000069470:Venlafaxine Hydrochloride / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000068438:Brimonidine Tartrate; D000077338:Latanoprost; D000069470:Venlafaxine Hydrochloride